BRPI0515413A - agentes para a profilaxia ou aperfeiçoamento de um distúrbio gastrointestinal funcional e de disfagia, e para a promoção da função da motilidade gastrointestinal, promotor de liberação de no e/ou serotonina, alimentos para a promoção da função da motilidade gastrointestinal, para a profilaxia ou aperfeiçoamento de disfagia e de um distúrbio gastrointestinal funcional, e para promover a liberação de no e/ou serotonina, embalagem comercial, uso de ácido glutámico, 5'-nucleotìdeo ou um sal do mesmo, e, métodos para a profilaxia ou aperfeiçoamento de um distúrbio gastrointestinal funcional e de disfagia, para promoção da função da motilidade gastrointestinal, e para a promoção de uma liberação de no e/ou serotonina - Google Patents

agentes para a profilaxia ou aperfeiçoamento de um distúrbio gastrointestinal funcional e de disfagia, e para a promoção da função da motilidade gastrointestinal, promotor de liberação de no e/ou serotonina, alimentos para a promoção da função da motilidade gastrointestinal, para a profilaxia ou aperfeiçoamento de disfagia e de um distúrbio gastrointestinal funcional, e para promover a liberação de no e/ou serotonina, embalagem comercial, uso de ácido glutámico, 5'-nucleotìdeo ou um sal do mesmo, e, métodos para a profilaxia ou aperfeiçoamento de um distúrbio gastrointestinal funcional e de disfagia, para promoção da função da motilidade gastrointestinal, e para a promoção de uma liberação de no e/ou serotonina

Info

Publication number
BRPI0515413A
BRPI0515413A BRPI0515413-8A BRPI0515413A BRPI0515413A BR PI0515413 A BRPI0515413 A BR PI0515413A BR PI0515413 A BRPI0515413 A BR PI0515413A BR PI0515413 A BRPI0515413 A BR PI0515413A
Authority
BR
Brazil
Prior art keywords
promote
gastrointestinal
serotonin
disorder
release
Prior art date
Application number
BRPI0515413-8A
Other languages
English (en)
Inventor
Hisayuki Uneyama
Tatsuro Tanaka
Kunio Torii
Shinichi Fujita
Original Assignee
Ajinomoto Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ajinomoto Kk filed Critical Ajinomoto Kk
Publication of BRPI0515413A publication Critical patent/BRPI0515413A/pt
Publication of BRPI0515413B1 publication Critical patent/BRPI0515413B1/pt
Publication of BRPI0515413B8 publication Critical patent/BRPI0515413B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/20—Synthetic spices, flavouring agents or condiments
    • A23L27/23—Synthetic spices, flavouring agents or condiments containing nucleotides
    • A23L27/235—Synthetic spices, flavouring agents or condiments containing nucleotides containing also amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/13—Nucleic acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A61K31/708—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid having oxo groups directly attached to the purine ring system, e.g. guanosine, guanylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Packages (AREA)
  • Saccharide Compounds (AREA)
  • Seasonings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

AGENTES PARA A PROFILAXIA OU APERFEIçOAMENTO DE UM DISTúRBIO GASTROINTESTINAL FUNCIONAL E DE DISFAGIA, E PARA A PROMOçãO DA FUNçãO DA MOTILIDADE GASTROINTESTINAL, PROMOTOR DE LIBERAçãO DE NO E/ OU SEROTONINA, ALIMENTOS PARA A PROMOçãO DA FUNçãO DA MOTILIDADE GASTROINTESTINAL, PARA A PROFILAXIA OU APERFEIçOAMENTO DE DISFAGIA E DE UM DISTúRBIO ASTROINTESTINAL FUNCIONAL, E PARA PROMOVER A LIBERAçãO DE NO E/ OU SEROTONINA, EMBALAGEM COMERCIAL, USO DE áCIDO GLUTáMICO, 5'-NUCLEOTìDEO OU UM SAL DO MESMO, E, MéTODOS PARA A PROFILAXIA OU APERFEIçOAMENTO DE UM DISTúRBIO GASTROINTESTINAL FUNCIONAL E DE DISFAGIA, PARA PROMOçãO DA FUNçãO DA MOTILIDADE GASTROINTESTINAL, E PARA A PROMOçãO DE UMA LIBERAçãO DE NO E/ OU SEROTONINA. é intencionado prover um agente e um alimento para a prevenção/ aperfeiçoamento de distúrbio digestivo funcional, que contém, como o ingrediente ativo, pelo menos um membro selecionado dentro ácido glutâmico, 5'-nucleotídeos e sais dos mesmos.
BRPI0515413A 2004-09-17 2005-09-16 uso de um sal de ácido glutâmico com aminoácido básico BRPI0515413B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2004271884 2004-09-17
JP2004-271884 2004-09-17
PCT/JP2005/017548 WO2006030980A1 (ja) 2004-09-17 2005-09-16 機能性消化管障害予防・改善剤及び食品

Publications (3)

Publication Number Publication Date
BRPI0515413A true BRPI0515413A (pt) 2008-07-22
BRPI0515413B1 BRPI0515413B1 (pt) 2021-04-27
BRPI0515413B8 BRPI0515413B8 (pt) 2021-05-25

Family

ID=36060214

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0515413A BRPI0515413B8 (pt) 2004-09-17 2005-09-16 uso de um sal de ácido glutâmico com aminoácido básico

Country Status (13)

Country Link
US (2) US20070218112A1 (pt)
EP (3) EP2103306B1 (pt)
JP (1) JP4124260B2 (pt)
KR (2) KR101153242B1 (pt)
CN (3) CN101052390B (pt)
AU (1) AU2005283297B2 (pt)
BR (1) BRPI0515413B8 (pt)
CA (1) CA2580692C (pt)
ES (2) ES2388609T3 (pt)
MX (1) MX2007003196A (pt)
PL (2) PL2103306T3 (pt)
RU (3) RU2407524C2 (pt)
WO (1) WO2006030980A1 (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5315996B2 (ja) * 2006-07-18 2013-10-16 味の素株式会社 総合経腸栄養組成物
JP5408882B2 (ja) * 2008-01-23 2014-02-05 ヤマサ醤油株式会社 唾液分泌促進剤
WO2009100265A2 (en) 2008-02-08 2009-08-13 Colgate-Palmolive Company Compositions and methods for the treatment of xerostomia
JPWO2009113594A1 (ja) * 2008-03-11 2011-07-21 味の素株式会社 機能性消化管障害予防・改善剤および食品
WO2010104175A1 (ja) 2009-03-13 2010-09-16 味の素株式会社 経口用組成物
US20150025147A1 (en) * 2012-03-02 2015-01-22 Kyowa Hakko Bio Co., Ltd Enhancer for eating activity and/or gastrointestinal activity
JP6067292B2 (ja) * 2012-03-19 2017-01-25 サッポロビール株式会社 セロトニン分泌促進剤
WO2013161815A1 (ja) * 2012-04-23 2013-10-31 味の素株式会社 グルタミン酸及びアルギニン高含有錠剤
JP2013224322A (ja) * 2013-07-03 2013-10-31 Yamasa Shoyu Co Ltd 唾液分泌促進剤
WO2015084158A1 (en) 2013-12-06 2015-06-11 N.V. Nutricia A pyrimidine derivative and a fatty acid source for use in the treatment of constipation
KR102233266B1 (ko) * 2014-07-09 2021-03-30 농업회사법인 주식회사 생명의나무 시티딜산, 아데닐산 또는 이들의 염을 유효성분으로 하는 헬리코박터 파이로리 감염 예방 또는 치료용 조성물
WO2016053085A1 (en) 2014-09-30 2016-04-07 N.V. Nutricia Composition comprising a uridine source and butyrate producing fibres for preventing gastrointestinal disorders
CN105902572A (zh) * 2016-02-26 2016-08-31 四川好医生攀西药业有限责任公司 一种治疗胃食管反流病的药物组合物及其制备方法和应用
CN106420790A (zh) * 2016-09-13 2017-02-22 北京大学 次黄嘌呤核苷酸在制备心肌力增强制剂中的用途
US11208568B2 (en) * 2017-05-17 2021-12-28 Elwha Llc Thermal signature control structures

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE786721A (fr) 1971-08-19 1973-11-16 Pechiney Ugine Kuhlmann Perfectionnement a la palettisation de charges elementaires nonrigides
JPS5920229B2 (ja) 1979-10-17 1984-05-11 沖電気工業株式会社 ジヤンクタ障害検出方式
JPS5888323A (ja) * 1981-11-20 1983-05-26 Riyoushiyoku Kenkyukai 乳幼児用成分栄養組成物
KR890001236B1 (ko) * 1985-10-02 1989-04-28 화이자 인코포레이티드 소염제 조성물의 제조방법
SE8704217D0 (sv) 1987-10-29 1987-10-29 Vinnars Erik Ab Aminosyrakomposition for parenteral neringstillforsel
DE4133366A1 (de) 1991-10-09 1993-04-15 Nycomed Arzneimittel Gmbh Zusammensetzung zur verhinderung von schaeden in geweben durch sauerstoffunterversorgung
JPH07114646B2 (ja) * 1993-01-04 1995-12-13 味の素株式会社 調味食品
US20040062802A1 (en) * 1998-04-02 2004-04-01 Hermelin Victor M. Maximizing effectiveness of substances used to improve health and well being
US6624150B2 (en) * 1999-02-26 2003-09-23 Inspire Pharmaceuticals, Inc. Method of treating gastrointestinal tract disease with purinergic receptor agonists
DE69910746T2 (de) * 1999-06-26 2004-06-17 B. Braun Melsungen Ag Wässrige Lösung für parenterale Nahrung
JP4010390B2 (ja) * 1999-09-20 2007-11-21 明治乳業株式会社 免疫賦活化組成物
MXPA02005161A (es) * 1999-12-22 2002-12-09 Inspire Pharmaceuticals Inc Metodo para tratamiento de enfermedades del aparato gastrointestinal con agonistas de los receptores purinergicos.
NL1014380C2 (nl) 2000-02-14 2001-08-15 Friesland Brands Bv Darmwandversterkend voedingsmiddel.
GB0009056D0 (en) * 2000-04-12 2000-05-31 Nestle Sa Composition comprising free amino acids
US20040063684A1 (en) * 2001-02-05 2004-04-01 Kamm Michael A. Treatment of oesophageal motility disorders and gastro-oesophageal reflux disease
US20040005304A1 (en) * 2002-07-08 2004-01-08 Mak Wood, Inc. Novel compositions and methods for treating neurological disorders and associated gastrointestinal conditions
AU2003295777A1 (en) * 2002-11-21 2004-06-18 Dss Global, Inc. Nucleotide based medicament and method of use for treatment of conditions in humans
JP2004271884A (ja) 2003-03-07 2004-09-30 Matsushita Electric Ind Co Ltd 光メモリ記録媒体および光メモリ装置
JP5092400B2 (ja) * 2004-06-28 2012-12-05 味の素株式会社 栄養組成物および消化管機能低下予防・改善用組成物

Also Published As

Publication number Publication date
MX2007003196A (es) 2007-05-16
KR101153242B1 (ko) 2012-06-08
EP2103306A3 (en) 2009-12-23
RU2007114297A (ru) 2008-10-27
RU2407524C2 (ru) 2010-12-27
EP1806134A4 (en) 2007-12-26
ES2388609T3 (es) 2012-10-16
AU2005283297A1 (en) 2006-03-23
EP2103306A2 (en) 2009-09-23
EP2103306B1 (en) 2012-06-06
CN101052390B (zh) 2011-12-14
RU2009110912A (ru) 2010-09-27
KR20090086450A (ko) 2009-08-12
EP1806134B1 (en) 2012-07-11
BRPI0515413B8 (pt) 2021-05-25
BRPI0515413B1 (pt) 2021-04-27
EP2305241A1 (en) 2011-04-06
WO2006030980A1 (ja) 2006-03-23
CA2580692C (en) 2014-03-18
PL2103306T3 (pl) 2012-12-31
CN102379891A (zh) 2012-03-21
KR20070053352A (ko) 2007-05-23
JPWO2006030980A1 (ja) 2008-05-15
ES2384294T3 (es) 2012-07-03
US20090291910A1 (en) 2009-11-26
JP4124260B2 (ja) 2008-07-23
CN101052390A (zh) 2007-10-10
AU2005283297B2 (en) 2011-12-08
EP1806134A1 (en) 2007-07-11
CA2580692A1 (en) 2006-03-23
RU2010136914A (ru) 2012-03-10
KR101086628B1 (ko) 2011-11-25
PL1806134T3 (pl) 2012-12-31
US20070218112A1 (en) 2007-09-20
CN102379865A (zh) 2012-03-21

Similar Documents

Publication Publication Date Title
BRPI0515413A (pt) agentes para a profilaxia ou aperfeiçoamento de um distúrbio gastrointestinal funcional e de disfagia, e para a promoção da função da motilidade gastrointestinal, promotor de liberação de no e/ou serotonina, alimentos para a promoção da função da motilidade gastrointestinal, para a profilaxia ou aperfeiçoamento de disfagia e de um distúrbio gastrointestinal funcional, e para promover a liberação de no e/ou serotonina, embalagem comercial, uso de ácido glutámico, 5'-nucleotìdeo ou um sal do mesmo, e, métodos para a profilaxia ou aperfeiçoamento de um distúrbio gastrointestinal funcional e de disfagia, para promoção da função da motilidade gastrointestinal, e para a promoção de uma liberação de no e/ou serotonina
CY1115416T1 (el) Συνθεση που περιεχει στατινες και ωμεγα-3 λιπαρα οξεα
BRPI0513333A (pt) detergente ácido não-clorado, concentrado, com multiplas funções, e método para uso do mesmo
GT200400233A (es) Composicion de reemplazo de carbohidratos y electrolitos
CY1112660T1 (el) Συμπληρωμα διατροφης που παρεχει ενεργεια σε σκελετικους μυες και που προστατευει την καρδιαγγειακη οδο
CL2004002015A1 (es) Derivados de amida, productos que las contienen, utiles para modificar el sabor de alimentos y medicamentos.
DK1737300T3 (da) Tilföring af et additiv til et produkt, som er egnet som menneskelig föde
BR112012022104A2 (pt) produtos e métodos para alimentos recheados, salgados, estáveis em prateleira.
TR201900012T4 (tr) Tatlandırıcı madde ve organik asit içeren bileşim ve bunun kullanımı.
BR112012015959A2 (pt) composições incluindo gengibre para a melhora ou prevenção de condições inflamatórias
PH12019550249A1 (en) Solid compositions for oral administration
BRPI0821579A8 (pt) Métodos para a preparação de amido aglomerado e um produto alimentício, amido aglomerado, produto alimentício, e, uso de um amido aglomerado
CL2017001237A1 (es) Métodos y composiciones para conservar la masa corporal magra y promover la pérdida de grasa durante la pérdida de peso.
ES1244074Y (es) Dispositivo ahumador para la preparacion de alimentos o bebidas
BR112012006872B8 (pt) composição, promotor de lipólise oral, inibidor de enzima de conversão de angiotensina oral, e, alimento ou bebida
BR112013013908A2 (pt) produtos alimentícios para crianças compreendendo grãos integrais hidrolisados
AR097423A1 (es) Compuestos con actividad plaguicida
BR112019024667A2 (pt) Uso de um agente bioativo, e, de uma composição
PH12020551929A1 (en) Chicken flavor improving agent
CL2015001104A1 (es) Composición de la alimentación para peces
AR063124A1 (es) Derivados de piperidin-benzo[1,4]oxazinas,composiciones farmaceuticas que los contienen y usos como inhibidores de la renina en el tratamiento y/o prevencion de trastornos asociados al sistema cardiovascular.
AR053176A1 (es) Anilidas de acido nicotinico, procedimiento para su preparacion y productos que los contienen para combatir hongos nocivos
AR108105A1 (es) Sales na₂-imp antiaglomerantes total o parcialmente deshidratadas, y composiciones de las mismas y métodos para reducir la aglomeración de composiciones
BRPI0509243A (pt) alimento funcional compreendendo de um emulsificador, uso deste e método para tratamento da obesidade
AR112517A1 (es) Concentrado salado conformado

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B15K Others concerning applications: alteration of classification

Ipc: A61K 31/7088 (2006.01), A23L 27/23 (2016.01), A23L

B15K Others concerning applications: alteration of classification

Ipc: A61K 31/198 (2006.01), A61K 31/7068 (2006.01), A61

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 16/09/2005, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME MEDIDA CAUTELAR DE 07/04/2021 - ADI 5.529/DF

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 16/09/2005 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B15V Prolongation of time limit allowed